This executive webinar will focus on two levers that you can pull to unlock further growth in customer-facing commercial spend: designating where promotional dollars are allocated and measuring how...
The session will introduce the ZS launch™ commitment signal, a predictive, prelaunch diagnostic that helps make organizational commitment visible, expose hidden structural risk and show where leade...
ZS quantifies how in silico methodologies in drug development can reduce trial costs by 63% and shorten timelines by 44%. Learn how with the ZS 4R framework.
While AI is reshaping industries, customer expectations regarding healthcare and HCPs are increasing, customer experience is declining and provider expectations for pharma are increasing. The cost ...
For decades, branded advertising was pharma’s default approach to patient activation. But rising complexity in care and new policy headwinds are exposing its limits. In this white paper, ZS explore...
Learn how AI transforms market research into a sensing engine that delivers real-time insights, compounds intelligence and improves commercial decisions.
Agentic AI changes what enterprises can do, but only with new decision systems. See how pharma leaders design for scale.
The Impact Live events in the U.S. have been nothing short of electric. Over 300 of the world’s leading pharma minds came together to spark fresh thinking, share bold ideas and reimagine what’s pos...
The pharma industry is navigating a landscape defined by scientific breakthroughs, AI-powered transformation and intensifying pricing pressures. In this 2026 outlook, ZS experts explore how leading...
Learn why clinically differentiated drugs underperform. Strengthen your pharma launch operating system to improve drug launch readiness and performance.
